We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.19%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
-$20M
(-1.1%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-15.76%
Top 10 Holdings %
Top 10 Hldgs %
16.25%
Holding
547
New
90
Increased
94
Reduced
221
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$32.2M |
| 2 |
Agilent Technologies
A
|
+$10.1M |
| 3 |
Incyte
INCY
|
+$9.9M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$9.65M |
| 5 |
ServiceNow
NOW
|
+$9.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$22.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$19.6M |
| 3 |
Capri Holdings
CPRI
|
+$18.6M |
| 4 |
Delta Air Lines
DAL
|
+$17.6M |
| 5 |
Nutanix
NTNX
|
+$17.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.83% |
| 2 | Technology | 24.23% |
| 3 | Consumer Discretionary | 14.95% |
| 4 | Industrials | 7.4% |
| 5 | Financials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWIR
351
DELISTED
Sierra Wireless
SWIR
| $318K | 0.02% |
+25,700
| New | +$353K |
|
352
NBT Bancorp
NBTB
$2.73B
| $314K | 0.02% |
+8,714
| New | +$321K |
|
353
Luxfer Holdings
LXFR
$458M
| $313K | 0.02% |
12,546
+581
| +5% | +$11.7K |
|
354
United Fire Group
UFCS
$1.32B
| $306K | 0.02% |
7,000
| – | – |
|
355
Calix
CALX
$2.32B
| $305K | 0.02% |
39,600
| – | – |
|
356
Eldorado Gold
EGO
$8.48B
| $301K | 0.02% |
+65,144
| New | +$254K |
|
357
Peoples Bancorp
PEBO
$1.46B
| $295K | 0.02% |
9,538
-1,284
| -12% | -$41.2K |
|
358
Safety Insurance
SAFT
$1.51B
| $288K | 0.02% |
+3,300
| New | +$283K |
|
359
LSB Industries
LXU
$824M
| $287K | 0.02% |
59,800
+8,961
| +18% | +$47.5K |
|
|
AQ
360
DELISTED
Aquantia Corp. Common Stock
AQ
| $285K | 0.02% |
+31,500
| New | +$269K |
|
361
Digi International
DGII
$2.55B
| $283K | 0.02% |
+22,300
| New | +$278K |
|
|
ABTX
362
DELISTED
Allegiance Bancshares
ABTX
| $280K | 0.02% |
8,300
+262
| +3% | +$9.48K |
|
|
CCXI
363
DELISTED
ChemoCentryx, Inc.
CCXI
| $275K | 0.02% |
19,820
+351
| +2% | +$4.01K |
|
364
Resources Connection
RGP
$133M
| $270K | 0.02% |
+16,300
| New | +$272K |
|
365
MYR Group
MYRG
$5.75B
| $267K | 0.02% |
7,718
-1,782
| -19% | -$58K |
|
|
JNCE
366
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $267K | 0.02% |
+43,112
| New | +$208K |
|
|
JE
367
DELISTED
Just Energy Group Inc
JE
| $266K | 0.02% |
2,373
+1,385
| +140% | +$163K |
|
368
Oaktree Specialty Lending
OCSL
$1.04B
| $264K | 0.01% |
+17,000
| New | +$253K |
|
369
Editas Medicine
EDIT
$411M
| $257K | 0.01% |
10,531
-87,943
| -89% | -$1.99M |
|
|
GNMK
370
DELISTED
GenMark Diagnostics, Inc
GNMK
| $255K | 0.01% |
36,000
-9,400
| -21% | -$61.9K |
|
|
BFIN
371
DELISTED
BankFinancial
BFIN
| $245K | 0.01% |
16,500
+4,900
| +42% | +$74.3K |
|
372
Barnes & Noble Education
BNED
$445M
| $244K | 0.01% |
580
-261
| -31% | -$142K |
|
373
Tompkins Financial
TMP
$1.43B
| $240K | 0.01% |
+3,149
| New | +$244K |
|
|
VRTV
374
DELISTED
VERITIV CORPORATION
VRTV
| $240K | 0.01% |
9,100
-3,537
| -28% | -$108K |
|
|
SRGA
375
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $231K | 0.01% |
1,283
| – | – |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q1 2019 Portfolio in Review
As of Q1 2019, PDT Partners held 547 positions worth $1.77B, down 1.1% from $1.79B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
PDT Partners withdrew a net $279M in Q1 2019, closing 118 positions and reducing 221 holdings. Its most notable exit was Morgan Stanley, an estimated $22.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, PDT Partners opened a new position in Bristol-Myers Squibb worth $30.8M.
- PDT Partners's largest Q1 2019 buy was Bristol-Myers Squibb: 645,994 shares worth $30.8M.
- PDT Partners added most to Anadarko Petroleum in Q1 2019, an estimated $9.65M increase.
- PDT Partners's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $11.6M.
- PDT Partners fully exited Morgan Stanley in Q1 2019, selling an estimated $22.6M.
- PDT Partners's ten largest holdings make up 16% of its $1.77B portfolio in Q1 2019.
- PDT Partners opened 90 new positions and closed 118 in Q1 2019.
- PDT Partners's portfolio value fell 1.1% quarter-over-quarter to $1.77B.
Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.